Compounded vs brand-name tirzepatide
The core decision for most patients: compounded tirzepatide (cash-pay, lower cost, not FDA-approved) vs brand-name Zepbound/Mounjaro (FDA-approved, higher cost). Here's how they differ.
| Compounded | Brand-name | |
|---|---|---|
| Maker | 503A / 503B pharmacies | Eli Lilly (Mounjaro/Zepbound) |
| FDA status | Not FDA-approved | FDA-approved |
| Active ingredient | Tirzepatide | Tirzepatide |
| From / month | $186 (NexLife)* | $299–$1,086 |
| Insurance | Cash-pay (HSA/FSA) | Possible with coverage |
| Oversight & potency | Pharmacy-dependent; ask for CoA | Manufacturer cGMP |
Pricing verified as of June 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.
Clinical model
Both contain tirzepatide. Brand-name products are FDA-approved and manufactured under cGMP; compounded tirzepatide is prepared by 503A/503B pharmacies and is not FDA-approved. With compounded products, ask which pathway fills your prescription and request a certificate of analysis — see 503A vs 503B.
Pharmacy & fulfillment
Brand-name flows through manufacturer/retail channels (LillyDirect self-pay or pharmacy). Compounded flows through 503A pharmacies or 503B outsourcing facilities. The choice affects cost, insurance eligibility, and regulatory category.
Strengths and trade-offs
Compounded
- Lower cash cost (from $186/mo)
- Flat-pricing options available
- Often HSA/FSA-eligible
- Not FDA-approved
- Quality depends on the pharmacy
- Generally not insurance-covered
Brand-name
- FDA-approved and cGMP-manufactured
- May be insurance-covered
- Manufacturer self-pay options (Zepbound)
- Higher cost than compounded
- Coverage depends on diagnosis/plan
Who each may be best for
Compounded may suit cash-pay patients prioritizing lower predictable cost who accept the non-FDA-approved category. Brand-name may suit those who want an FDA-approved product or have coverage. A licensed clinician determines eligibility either way. See Zepbound vs compounded cost.
Questions
Is compounded tirzepatide as good as brand-name?
Both contain tirzepatide, but compounded is not FDA-approved and quality depends on the pharmacy, while brand-name is FDA-approved and cGMP-manufactured. Discuss with a licensed clinician. See NexLife pricing
Why is compounded tirzepatide cheaper?
It's a different regulatory category — prepared by 503A/503B pharmacies and dispensed cash-pay rather than sold as an FDA-approved branded product.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.